Shopping Cart 0
Cart Subtotal
AED 0

China Biologic Products Inc (CBPO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. China Biologic's other product includes placenta polypeptide. The company provides services such as plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. China Biologic is headquartered in Beijing, China.

China Biologic Products Inc (CBPO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

China Biologic Products to Raise USD590 Million in Private Placement of Shares 11

Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13

CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15

Equity Offering 16

China Biologic Products Raises Funds through Public Offering of Shares 16

China Biologic Prices Public Offering of Shares for USD73.5 Million 18

China Biologic Prices Public Offering of Shares for USD30 Million 19

Acquisition 21

China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21

China Biologic Products Inc-Key Competitors 22

China Biologic Products Inc-Key Employees 23

China Biologic Products Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Nov 01, 2018: China Biologic reports financial results for the third quarter of 2018 25

Aug 03, 2018: China Biologic reports financial results for the second quarter of 2018 31

May 04, 2018: China Biologic Reports Financial Results For First Quarter Of 2018 37

May 04, 2018: China Biologic Announces First Quarter 2018 Financial Results 40

Feb 28, 2018: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 43

Nov 01, 2017: China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 47

Aug 02, 2017: China Biologic Reports Financial Results for the Second Quarter of 2017 51

May 03, 2017: China Biologic Reports Financial Results for the First Quarter of 2017 55

Feb 23, 2017: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 58

Corporate Communications 62

Aug 13, 2018: China Biologic names Bing Li as new CEO 62

Legal and Regulatory 63

Aug 28, 2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman 63

Other Significant Developments 64

Jan 08, 2018: China Biologic Announces Corporate Update 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

China Biologic Products Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

China Biologic Products to Raise USD590 Million in Private Placement of Shares 11

Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13

CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15

China Biologic Products Raises Funds through Public Offering of Shares 16

China Biologic Prices Public Offering of Shares for USD73.5 Million 18

China Biologic Prices Public Offering of Shares for USD30 Million 19

China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21

China Biologic Products Inc, Key Competitors 22

China Biologic Products Inc, Key Employees 23

China Biologic Products Inc, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

China Biologic Products Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

China Biologic Products Inc (China Biologic) is a biopharmaceutical company that offers plasma collection, research and development, production, commercialization of biopharmaceutical products and development of treatment products. The company manufactures, develops, and markets biologic products for the prevention and treatment of various diseases. Its plasma products include human albumin, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin for intravenous injection, human hepatitis B immunoglobulin, thymopolypeptides injection, human immunoglobulin, and human coagulation factor VIII. China Biologic's other product includes placenta polypeptide. The company provides services such as plasma collection, research and development, production, and commercialization of biopharmaceutical products. It offers products to hospitals and other healthcare facilities in China. China Biologic is headquartered in Beijing, China.

China Biologic Products Inc (CBPO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

China Biologic Products to Raise USD590 Million in Private Placement of Shares 11

Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13

CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15

Equity Offering 16

China Biologic Products Raises Funds through Public Offering of Shares 16

China Biologic Prices Public Offering of Shares for USD73.5 Million 18

China Biologic Prices Public Offering of Shares for USD30 Million 19

Acquisition 21

China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21

China Biologic Products Inc-Key Competitors 22

China Biologic Products Inc-Key Employees 23

China Biologic Products Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Financial Announcements 25

Nov 01, 2018: China Biologic reports financial results for the third quarter of 2018 25

Aug 03, 2018: China Biologic reports financial results for the second quarter of 2018 31

May 04, 2018: China Biologic Reports Financial Results For First Quarter Of 2018 37

May 04, 2018: China Biologic Announces First Quarter 2018 Financial Results 40

Feb 28, 2018: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 43

Nov 01, 2017: China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 47

Aug 02, 2017: China Biologic Reports Financial Results for the Second Quarter of 2017 51

May 03, 2017: China Biologic Reports Financial Results for the First Quarter of 2017 55

Feb 23, 2017: China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 58

Corporate Communications 62

Aug 13, 2018: China Biologic names Bing Li as new CEO 62

Legal and Regulatory 63

Aug 28, 2018: China Biologic responds to lawsuit filed in Cayman Islands by former Chairman 63

Other Significant Developments 64

Jan 08, 2018: China Biologic Announces Corporate Update 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

China Biologic Products Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

China Biologic Products Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

China Biologic Products Inc, Deals By Therapy Area, 2012 to YTD 2018 8

China Biologic Products Inc, Medical Devices Deals, 2012 to YTD 2018 9

China Biologic Products Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

China Biologic Products to Raise USD590 Million in Private Placement of Shares 11

Consortium of Investors to Acquire Remaining Shares in China Biologic Products for USD3.9 Billion 13

CCRE Holdings to Acquire Remaining 94.9% Stake in China Biologic Products 15

China Biologic Products Raises Funds through Public Offering of Shares 16

China Biologic Prices Public Offering of Shares for USD73.5 Million 18

China Biologic Prices Public Offering of Shares for USD30 Million 19

China Biologic Products Acquires Remaining 15.3% Stake in Guizhou Taibang Biological Products for USD62.5 Million 21

China Biologic Products Inc, Key Competitors 22

China Biologic Products Inc, Key Employees 23

China Biologic Products Inc, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

China Biologic Products Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.